Natixis’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Natixis’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-27,500	Closed	-$1.28M	–	1169
2023 Q2	$1.28M	Buy	+27,500	New	+$950K	0.01%	498

Natixis's DICE Position: Q3 2023 in Review

Natixis sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 27,500 shares — an estimated $1.28M sold.

Natixis first reported a position in DICE in Q2 2023 and held it in 1 quarter. The position peaked at $1.28M in Q2 2023. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Natixis reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Natixis sold 27,500 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $1.28M.
Natixis first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2023 and held it in 1 quarter.
Natixis's DICE Therapeutics, Inc. Common Stock position peaked at $1.28M in Q2 2023.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Natixis's 13F filing for Q3 2023, filed 14 Nov 2023.